PYXS
Pyxis Oncology Inc
2.90$
-9.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -446.0% | -128.3% | – | – | -567.0% | – | -612.2% | – | -94.5% | – | – | -615.2% | |
| – | 20.2% | 6.9% | – | – | 16.2% | – | 19.0% | – | 26.2% | – | – | 37.9% | |
| – | 94.0% | 26.8% | – | – | 81.5% | – | 106.9% | – | 18.9% | – | – | 107.7% | |
| – | -67.5% | -134.8% | – | – | -195.7% | – | -62.6% | – | 25.9% | – | – | 47.0% | |
| – | 0.0% | 1.5% | – | – | 0.0% | – | 0.0% | – | 0.0% | – | – | 0.1% | |
| – | 299.1% | -114.6% | – | – | 783.6% | – | 542.7% | – | 147.3% | – | – | 592.5% | |
| – | 0.0% | -1.2% | – | – | -224.9% | – | -2.4% | – | – | – | – | – | |
| – | -0.7% | 356.2% | – | – | 1.5% | – | -2.4% | – | 6.1% | – | – | 96.3% | |
| – | -147.7% | 113.4% | – | – | 218.0% | – | -71.8% | – | 58.9% | – | – | 73.6% | |
| – | -446.0% | -129.7% | – | – | -567.0% | – | -612.2% | – | -94.5% | – | – | -615.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.